DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Vezér B, Buzás E, Sebeszta M. et al
Authorized manufacturing changes for therapeutic monoclonal antibodies (mAbs) in European Public Assessment Report (EPAR) documents.
Curr Med Res Opin 2016;
32 (05) 829-834
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.